The authors were clear that stronger evidence is needed before GLP-1 drugs are seriously considered for infections, dementia or other non-cardiometabolic uses
However, the use of senolytics, which eliminate these senescent cells, or senomorphics, which modify SASP secretion, could impair wound healing, including that associated with tumor-related wounds
Key Mergers and Acquisitions January 2026: Eli Lilly and Company acquired a biotech firm developing next-generation dual GLP-1/GIP agonists to expand its obesity and diabetes portfolio beyond Mounjaro and Zepbound
Three different volumes for the exact same milligram dose, all because of concentration differences
Looking on a Monday morning, we found the quickest appointment was in just 25 minutes, and there were nine options within an hour
Meill on yli 4 miljoonaa tyytyvist asiakasta maailmanlaajuisesti ja olemme lsn yli 40 maassa eri puolilla Eurooppaa